Loading clinical trials...
Loading clinical trials...
Prospective Observational Multi Cohort Study of Intranasal MuSE Cell Derived Exosomes, MuSE Stem Cells, and Combination Therapy Delivered Via the Kurve Therapeutics ViaNase Device in Patients Receiving International Regenerative Treatments
Conditions
Locations
1
Mexico
Stem Solutions
Monterrey, Nuevo León, Mexico
Start Date
June 1, 2026
Primary Completion Date
January 1, 2028
Completion Date
January 30, 2029
Last Updated
April 9, 2026
NCT07252713
NCT07488429
NCT04630392
NCT04521881
NCT07351305
NCT07455136
Lead Sponsor
Healing Hope International
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions